$NVAX EU has always maintained that Novavax is going to be the last vaccine provider that falls under their Advance Purchase Agreement. With the Contract signing, Novavax could get 50% downpayment as advance payment. 200 million doses at $16/dose is $3.2 billion dollars and 50% of that is $1.6 billion - So, if EU and Novavax signs a contract this week, Novavax could get that money this month of May, even if they will deliver late 2021 or 2022. And by the way, other mRNA vaccine contacts goes up to 2023. This EU downpayment could be sales money reported in the 2nd quarter earnings of Novavax.